Evidence map›Paper›PMID 32457477›Full record

ArticleScientific reports2020

Use of synergistic mixture of chelating agents for in situ LDH growth on the surface of PEO-treated AZ91.

E Petrova, M Serdechnova, T Shulha, S V Lamaka, D C F Wieland, P Karlova, C Blawert, M Starykevich, M L Zheludkevich

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

E PetrovaFaculty of Chemistry, Belarusian State University, Nezavisimosti Avenue 4, 220030, Minsk, Belarus.
M SerdechnovaMagIC-Magnesium Innovation Center, Helmholtz-Zentrum Geesthacht, Max-Planck-Straβe 1, 21502, Geesthacht, Germany. maria.serdechnova@hzg.de.
T ShulhaMagIC-Magnesium Innovation Center, Helmholtz-Zentrum Geesthacht, Max-Planck-Straβe 1, 21502, Geesthacht, Germany.
S V LamakaMagIC-Magnesium Innovation Center, Helmholtz-Zentrum Geesthacht, Max-Planck-Straβe 1, 21502, Geesthacht, Germany.
D C F WielandMagIC-Magnesium Innovation Center, Helmholtz-Zentrum Geesthacht, Max-Planck-Straβe 1, 21502, Geesthacht, Germany.
P KarlovaMagIC-Magnesium Innovation Center, Helmholtz-Zentrum Geesthacht, Max-Planck-Straβe 1, 21502, Geesthacht, Germany.
C BlawertMagIC-Magnesium Innovation Center, Helmholtz-Zentrum Geesthacht, Max-Planck-Straβe 1, 21502, Geesthacht, Germany.
M StarykevichDepartment of Materials and Ceramic Engineering, CICECO - Aveiro Institute of Materials, University of Aveiro, 3810-193, Aveiro, Portugal.
M L ZheludkevichMagIC-Magnesium Innovation Center, Helmholtz-Zentrum Geesthacht, Max-Planck-Straβe 1, 21502, Geesthacht, Germany.
Helmholtz-Zentrum Hereon · DEBelarusian State University · BYUniversity of Aveiro · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The principal possibility to grow layered double hydroxide (LDH) at ambient pressure on plasma electrolytic oxidation (PEO) treated magnesium alloy AZ91 in the presence of chelating agents is demonstrated for the first time. It avoids hydrothermal autoclave conditions, which strongly limit wide industrial application of such coating systems, and the presence of carbonate ions in the electrolyte, which lead to the formation of "passive" non-functionalizable LDH. A combination of chelating agents (sodium diethylenetriamine-pentaacetate (DTPA) and salicylate) were introduced to the treatment solution. The role of each additive and the influence of treatment bath composition on the LDH formation processes are discussed. A synergistic effect of DTPA and salicylate during LDH formation is discovered and its possible explanation is proposed.

Identifiers

PMID32457477
PMCPMC7250903
OpenAlexW3032313446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.